Guidelines on muscle-invasive and metastatic bladder cancer

November 2013
National Guideline Clearinghouse;11/4/2013, p1
No abstract available.


Related Articles

  • Post-RC Survival Has Improved.  // Renal & Urology News;Oct2015, Vol. 14 Issue 8, p21 

    The article reports on the improvement of the survival rate of patients that experienced radical cystectomy (RC) for muscle-invasive bladder cancer.

  • 2012 American Society of Clinical Oncology Annual Meeting: Accelerated chemotherapy given before surgery benefits patients with muscleinvasive bladder cancer.  // Biomedical Market Newsletter;5/25/2012, Vol. 21, p1 

    The article informs that performing chemotherapy before surgery benefits patients with muscle-invasive bladder cancer.

  • COX-2 expression associated with bladder CIS outcome. Prescott, Lawrence M. // Urology Times;Sep2001, Vol. 29 Issue 9, p14 

    Focuses on the association of bladder carcinoma with cyclooxygenase 2 inhibitors. Increase risk of bladder cancer and recurrence; Involvement in cell proliferation; Absence of muscle-invasive carcinoma.

  • Podium Session 3: Oncology (Bladder) June 24,2013,1050-1150.  // Canadian Urological Association Journal;May/Jun2013, Vol. 7 Issue 5/6, Supp 2, pS31 

    The article presents abstracts on medical topics which include utilization and impact of perioperative chemotherapy in muscle-invasive bladder cancer, radical cystectomy with and without neoadjuvant chemotherapy in muscle-invasive bladder cancer and radical cystectomy (RC) in bladder cancer.

  • Bladder Cancer.  // Current Medical Literature: Urology;2008, Vol. 14 Issue 4, p104 

    This section presents studies about bladder cancer published in various medical journal about urology. These include "EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder," "Low-Dose Chemoradiotherapy Followed by Partial or Radical Cystectomy Against Muscle-Invasive Bladder...

  • Use of Radical Cystectomy for Patients With Invasive Bladder Cancer. Gore, John L.; Litwin, Mark S.; Lai, Julie; Yano, Elizabeth M.; Madison, Rodger; Setodji, Claude; Adams, John L.; Saigal, Christopher S. // JNCI: Journal of the National Cancer Institute;06/02/2010, Vol. 102 Issue 11, p802 

    Background: Evidence-based guidelines recommend radical cystectomy for patients with muscle-invasive bladder cancer. However, many patients receive alternate therapies, such as chemotherapy or radiation. We examined factors that are associated with the use of radical cystectomy for invasive...

  • Metastasis of Non-Muscle-Invasive Bladder Cancer Into the Thyroid Gland: A Literature Review Accompanied by a Rare Case. Tuncer, Murat; Faydaci, Gokhan; Altin, Gokhan; Erdogan, Banu Atalay; Kibar, Sermin; Sanli, Arif; Bilgici, Dilek // Korean Journal of Urology;Mar2014, Vol. 55 Issue 3, p222 

    Bladder cancer is the most prevalent malignancy of the urinary tract. About 90% of bladder cancers are urothelial carcinomas. Seventy percent of cases newly diagnosed are superficial diseases; roughly 30% of newly diagnosed cases are muscle-invasive metastatic diseases. Bladder urothelial...

  • Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives. Ohishi, Tomokazu; Koga, Fumitaka; Migita, Toshiro // International Journal of Molecular Sciences;2016, Vol. 17 Issue 1, p1 

    Bladder cancer (BC), the most common cancer arising from the human urinary tract, consists of two major clinicopathological phenotypes: muscle-invasive bladder cancer (MIBC) and non-muscle-invasive bladder cancer (NMIBC). MIBC frequently metastasizes and is associated with an unfavorable...

  • Clinical digest. Perioperative chemotherapy for muscle-invasive bladder cancer is still uncommon.  // Nursing Standard;4/30/2014, Vol. 28 Issue 35, p16 

    The article discusses research in the article "Perioperative Chemotherapy for Muscle-Invasive Bladder Cancer" by C. Booth et al. in a 2014 issue of the journal "Cancer", which found that perioperative chemotherapy for muscle invasive bladder cancer is uncommon.

  • Radiotherapy plus Chemotherapy in Muscle-Invasive Bladder Cancer.  // New England Journal of Medicine;7/26/2012, Vol. 367 Issue 4, p379 

    A letter to the editor is presented in response to the article "Radiotherapy plus Chemotherapy in Muscle-Invasive Bladder Cancer" that appeared in the June 2012 issue.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics